December 17, 2025 · Form 4 insider transaction
Gayer Charles K bought 471,000 shares of BioCryst Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Annual award of restricted stock units which will vest 25% on each of the first, second, third and fourth anniversaries of the date of grant.